Search Results - "Buraglio, M."

A Bioequivalence Study of Recombinant Human Follicle-Stimulating Hormone Injection Versus Recombinant Human Follitropin For Injection in Healthy Chinese Adult Women.

Authors: Zhang, Jigang Zhang, Mingjian Xue, Wenyuan et al.

Source: Drugs in R&D. Sep2025, Vol. 25 Issue 3, p241-252. 12p.

A Single-Group, Open-Label Study on the Systemic Bioavailability, Safety, and Local Tolerability of a New L-Thyroxine/Escin Gel Formulation in Healthy Women.

Authors: Gori, Giovanni De Negri, Ferdinando Fioravanti, Anna et al.

Source: Future Pharmacology. Sep2025, Vol. 5 Issue 3, p33. 13p.

Author Index.

Source: Gynecological Endocrinology. 2004 Suppl 1, Vol. 18, p379-389. 11p.

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single‐Dose, Two‐Period, Two‐Sequence Crossover Study.

Authors: Chen, Jiangying Zhuang, Jialang Wu, Jingguo et al.

Source: Clinical Pharmacology in Drug Development. Feb2019, Vol. 8 Issue 2, p217-222. 6p.

Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer.

Authors: Sambe T Imamura CK Hida N et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Dec 08; Vol. 95 (1), pp. 123. Date of Electronic Publication: 2025 Dec 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Expert opinion on clinical experience with subcutaneous interferon beta‐1a in multiple sclerosis patients with different disease activity profiles.

Authors: Bohlega, Saeed Alroughani, Raed Alkhawajah, Mona et al.

Source: Neurology & Clinical Neuroscience. Sep2019, Vol. 7 Issue 5, p260-266. 7p.

Electrically regulated cell‐based intervention for viral infections.

Authors: Newmyer, Sherri Ssemadaali, Marvin A. Radhakrishnan, Harikrishnan et al.

Source: Bioengineering & Translational Medicine. Mar2023, Vol. 8 Issue 2, p1-11. 11p.

Interferon Lambda as a Potential New Therapeutic for Hepatitis C.

Authors: Miller, Dennis M. Klucher, Kevin M. Freeman, Jeremy A. et al.

Source: Annals of the New York Academy of Sciences. Nov2009, Vol. 1182 Issue 1, p80-87. 8p. 1 Diagram, 1 Chart, 2 Graphs.

Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial.

Authors: Namdari, Rostam Luzon, Constanza Cadieux, Jay A. et al.

Source: Neurology & Therapy. Jun2022, Vol. 11 Issue 2, p781-796. 16p.

Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders.

Authors: Singh, Som P. William, Matthew Malavia, Mira et al.

Source: Membranes. May2022, Vol. 12 Issue 5, p499-499. 15p.

Recombinant Human Interferon-β-1a (Rebif) vs Recombinant Interferon-β-1b (Betaseron) in Healthy Volunteers: A Pharmacodynamic and Tolerability Study.

Authors: Buraglio, M. Trinchard-Lugan, I. Munafo, A. et al.

Source: Clinical Drug Investigation. 1999, Vol. 18 Issue 1, p27-34.

Lack of Effect of Food on the Bioavailability of Oral Azithromycin Tablets.

Authors: Simicevic, V.N. Erceg, D. Dohoczky, C. et al.

Source: Clinical Drug Investigation. 1998, Vol. 16 Issue 5, p405-410.

Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study.

Authors: Rutgeerts, P. Lemmens, L. Van Assche, G. et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2003, Vol. 17 Issue 2, p185-192. 8p. 3 Charts.

Solubilization of Human Interferon ß-1b Inclusion Body Proteins by Organic Solvents.

Authors: Nekoufar, Samira Fazeli, Ahmad Fazeli, Mohammad Reza

Source: Advanced Pharmaceutical Bulletin. 2020, Vol. 10 Issue 2, p233-238. 6p.

Evaluation of the predictive performance of physiologically based pharmacokinetic models for intramuscular injections of therapeutic proteins.

Authors: Chow, Timothy W. Wright, Matthew R. Hop, Cornelis E. C. A. et al.

Source: Xenobiotica. Dec2019, Vol. 49 Issue 12, p1423-1433. 11p.

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors.

Authors: Roze, Joline Sendino Garví, Elena Stelloo, Ellen et al.

Source: Cancers. Feb2021, Vol. 13 Issue 3, p368. 1p.

A single-center, randomized, open-label, two-period, crossover, fasted bioequivalence study: comparing recombinant human follicle-stimulating hormone for injection (JZB30) with Gonal-f® in healthy Chinese female participants.

Authors: Chen Z Yu Q Feng S et al.

Source: Frontiers in pharmacology [Front Pharmacol] 2025 Nov 10; Vol. 16, pp. 1678830. Date of Electronic Publication: 2025 Nov 10 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

The best execution of the DuoStim strategy (double stimulation in the follicular and luteal phase of the same ovarian cycle) in patients who are poor ovarian responders.

Authors: Luo, Yanqun Sun, Li Dong, Mei et al.

Source: Reproductive Biology & Endocrinology. 10/15/2020, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.

Authors: Lammerich, Andreas Bias, Peter Gertz, Beate

Source: International Journal of Women's Health. Jul2015, Vol. 7, p707-716. 10p.

Pharmacokinetics and Safety Profile of DA-3803, a Proposed Biosimilar of Recombinant Human Chorionic Gonadotropin, in Healthy Subjects.

Authors: Cha, Yu-Jung Kim, Kyoung-Ah Oh, Tae et al.

Source: BioDrugs. Jun2015, Vol. 29 Issue 3, p199-205. 7p. 3 Charts, 2 Graphs.